ID

19414

Descripción

NCT01117584 Astellas Phase 2b, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12- Week Treatment with ASP1941 in Combination with Metformin in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone.

Palabras clave

  1. 30/12/16 30/12/16 -
  2. 4/2/17 4/2/17 -
Subido en

30 de diciembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

End of Study: End of Treatment/ Premature Discontinuation [DS_1] NCT01117584

End of Study: End of Treatment/ Premature Discontinuation [DS_1] NCT01117584

General Information
Descripción

General Information

Date of Last Treatment Evaluation Through Visit 7
Descripción

Date of Collection

Tipo de datos

datetime

Study day of collection
Descripción

Study day of collection

Tipo de datos

text

Did subject complete Study Drug Treatment?
Descripción

Complete Study Drug Treatment

Tipo de datos

boolean

If no, please provide details below.
Descripción

Study Drug Treatment

Tipo de datos

text

End of Treatment
Descripción

End of Treatment

Tipo de datos

text

If reason is `Withdrawal by Subject` please speficy follow-up allowance
Descripción

Withdrawal by subject

Tipo de datos

integer

Date of Withdrawal
Descripción

Date of Withdrawal

Tipo de datos

date

Did AE result in death?
Descripción

Result in Death

Tipo de datos

text

If "Protocol Violation", please specify
Descripción

Protocol Violation

Tipo de datos

text

If "Other" please specify
Descripción

Other

Tipo de datos

text

Similar models

End of Study: End of Treatment/ Premature Discontinuation [DS_1] NCT01117584

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
General Information
Date of Collection
Item
Date of Last Treatment Evaluation Through Visit 7
datetime
Study day of collection
Item
Study day of collection
text
Complete Study Drug Treatment
Item
Did subject complete Study Drug Treatment?
boolean
Study Drug Treatment
Item
If no, please provide details below.
text
Item
End of Treatment
text
Code List
End of Treatment
CL Item
Not fulfill inclusion or exclusion criteria  (1)
CL Item
Adverse event (2)
CL Item
Lack of efficacy (3)
CL Item
Withdrawal by subject (4)
CL Item
Subject lost to follow-up (5)
CL Item
Protocol violation (6)
CL Item
Randomized/registered but never received/dispensed study drug (7)
CL Item
Other (8)
Item
If reason is `Withdrawal by Subject` please speficy follow-up allowance
integer
Code List
If reason is `Withdrawal by Subject` please speficy follow-up allowance
CL Item
Allows follow-up after withdrawal (1)
CL Item
Does not allow follow-up after withdrawal (2)
Date of Withdrawal
Item
Date of Withdrawal
date
Item
Did AE result in death?
text
Code List
Did AE result in death?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Protocol Violation
Item
If "Protocol Violation", please specify
text
Other
Item
If "Other" please specify
text

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial